Meet and hear first-hand from industry's most influential minds and leading KOLs.
Building sustainable value through new relationships.
Bio€quity Europe is the industry’s premier CEO and investor conference. Join us at this exclusive event for biotech decision makers. Join the discussion in Dublin or attend from home via a digital pass. Plus take advantage of two bonus days of digital one-to-one meetings.
BioCentury and BayHelix present the East-West BioPharma Summit (Oct. 2-4, 2023, Boston/Cambridge). Along with two additional bonus days of virtual 1x1 meetings (Oct. 5-6, 2023).
Learn, Network, Meet Your Next Investor or Partner.
Hear from industry's most influential minds and leading experts
Gain powerful insight, tangible solutions, and practical advice
Meet emerging new companies selected to present by BioCentury
Access related content hand-picked by BioCentury industry experts
Research presenting companies through BioCentury's BCIQ database
Understand the landscape via exclusive reports and “Scene Setter” presentations
Meet potential partners and investors
Schedule 1x1 meetings with industry peers
Forge lasting relationships
Join the many companies that support BioCentury-BayHelix East-West Biopharma Summit and Bio€quity Europe.
Tell your story; find the right investors
Looking for investors or partners? Apply now to be considered for the BioCentury-BayHelix East-West Biopharma Summit or Bio€quity Europe Presenting Company Class. Presenting Companies can expect to receive significantly more 1x1 meeting requests than non-presenters.
The drug price-setting provisions of the Inflation Reduction Act (IRA) will reconfigure the commercial landscape in the U.S., forcing biopharma companies and their investors to develop new strategies for R&D and business success.
Hosted by BioCentury & Putnam Associates
In this webinar, key opinion leaders from Owkin, Bristol-Myers Squibb and CancerLinQ gather to discuss how data-driven Covariate Adjustment improves clinical trials by increasing statistical power and widening eligibility criteria.
Hosted by BioCentury & Owkin
Industry KOL's discuss the current state of AI in oncology, and how building research networks in a privacy-preserving way is key for unlocking insights from the vast amount of patient data in hospitals and research centers to accelerate drug discovery.
Hosted by BioCentury & Owkin
BioCentury and BayHelix present the East-West BioPharma Summit (Nov. 14-16, 2022, SF Bay Area). Along with two additional bonus days of virtual 1x1 meetings Nov. 17 & 18, 2022.
Hotbeds of Newco Formation in Europe
Europe’s premier international showcase for financial dealmakers and biopharma executives to meet rising biotechs – join the discussion in Milan or attend the full event via our digital platform, May 16-18, 2022.
Armed with unprecedented funds, Chinese biotechs and medtechs are racing across the Bridge to Innovation.
The 8th BioCentury-BayHelix China Healthcare Summit is a propitious time to showcase how the China story promises to have a lasting impact on the global biopharma industry.
Europe's premier international showcase for financial dealmakers and biopharma C-suite executives to meet rising biotechs.
BioCentury and BayHelix Present: The 7th China Healthcare Summit - Doubling Down on Innovation.
BioCentury and BayHelix Present: The 6th China Healthcare Summit - China In The World.
Bio€quity Europe pioneered the turf-neutral concept, creating an open door for all members of the financial community and business development and licensing professionals to do business with independently selected Presenting Companies.
BioCentury and BayHelix Present: The 5th China Healthcare Summit - China's Globally Facing Future. The China Summit is a VIP-only event for busy biopharma and life sciences executives and investors to get a first-hand look at the innovation, business and policy transformations taking place in China. The conference is THE place to meet the right Chinese investors and partners in an intimate setting.
Now celebrating its 19th meeting, Bio€quity Europe is the seminal industry event for financial dealmakers looking for investor-validated life science companies positioning themselves to attract capital, and for pharmaceutical licensing professionals to assess top prospects.
USAIC has created an ecosystem committed to driving a global dialogue on BioPharma & Healthcare innovation, attracting a diverse mix of senior industry professionals and catalyzing partnerships, new ideas, networks and regulatory reform. This unique platform creates mutually beneficial opportunities and relationships for the global Life Sciences & Healthcare industry.
Featuring - Chair and Master of Ceremonies (Emcee)– Dr. Andrew Plump, President of R&D, Takeda Pharmaceuticals
Panel Discussions and Fireside Chats covering: